The basic objective of this research is the elucidation of the mechanisms of cell transformation induced by avian oncogenic viruses. Special emphasis will be placed on the oncogenes whose functions are related to early steps of signal transduction pathways. As representatives, we will focus our efforts on the activities of the Src family of tyrosine kinases and small molecular weight proteins containing only SH2/SH3 domains. Biochemical analysis of cell transformation by tyrosine kinase genes includes the mechanisms of regulation of c-Src kinase, particularly how its kinase activity is regulated by another kinase and by phosphatases, and the role of the Ras protein in src-induced transformation, and the role of serine/threonine protein kinases as effectors of the v-Src kinase. To understand how a small protein containing only SH2 and SH3 domain can cause cell transformation, we will analyze the specificity of the interactions between SH2 domains and phosphotyrosine-containing proteins, structures involved in the interactions, the significance of the small SH2 containing proteins in protection of tyrosine phosphorylated proteins from phosphatases, and the identification and characterization of activated kinases and its substrates in transformed cells. We will also investigate the possible interactions between small SH2/SH3 proteins and growth factor receptors, other known signal transduction proteins, and the role of Crk and other related proteins in induction of cell proliferation. Finally, we will characterize the product of a new receptor tyrosine kinase isolated from a transforming virus, and identify its ligand.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Unknown (R35)
Project #
2R35CA044356-08
Application #
2091447
Study Section
Special Emphasis Panel (SRC (88))
Project Start
1994-07-26
Project End
2001-04-30
Budget Start
1994-07-26
Budget End
1995-04-30
Support Year
8
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Internal Medicine/Medicine
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Kirsch, Kathrin; Kensinger, Margaret; Hanafusa, Hidesaburo et al. (2002) A p130Cas tyrosine phosphorylated substrate domain decoy disrupts v-crk signaling. BMC Cell Biol 3:18
Kirsch, K H; Georgescu, M M; Shishido, T et al. (2001) The adapter type protein CMS/CD2AP binds to the proto-oncogenic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction. J Biol Chem 276:4957-63
Shishido, T; Akagi, T; Chalmers, A et al. (2001) Crk family adaptor proteins trans-activate c-Abl kinase. Genes Cells 6:431-40
Shishido, T; Akagi, T; Ouchi, T et al. (2000) The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. Proc Natl Acad Sci U S A 97:6439-44
Akagi, T; Shishido, T; Murata, K et al. (2000) v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc Natl Acad Sci U S A 97:7290-5
Wong, B R; Besser, D; Kim, N et al. (1999) TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell 4:1041-9
Georgescu, M M; Kirsch, K H; Shishido, T et al. (1999) Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB. Mol Cell Biol 19:1171-81
Besser, D; Bromberg, J F; Darnell Jr, J E et al. (1999) A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol Cell Biol 19:1401-9
Kirsch, K H; Georgescu, M M; Ishimaru, S et al. (1999) CMS: an adapter molecule involved in cytoskeletal rearrangements. Proc Natl Acad Sci U S A 96:6211-6
Georgescu, M M; Kirsch, K H; Akagi, T et al. (1999) The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. Proc Natl Acad Sci U S A 96:10182-7

Showing the most recent 10 out of 94 publications